Timing and rate of reimbursement for cystic fibrosis modulator therapies in EU countries
Journal of Cystic Fibrosis · 2026-07
DOI: 10.1016/j.jcf.2026.07.008 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Cystic Fibrosis, 2026-07. Verfasst von Enrico Costa und 10 weiteren Autor:innen. Beteiligte Einrichtung: Italian Medicines Agency (AIFA), Rome, Italy. Die Arbeit nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Italian Medicines Agency (AIFA), Rome, Italy.
- Section of Pharmacology, Department of Diagnostics and Public Health, University of Verona, Verona, Italy.
- Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, the Netherlands.
- Cystic Fibrosis Centre, IRCCS Istituto Giannina Gaslini, Genoa, Italy.
- Eurordis-Rare Diseases Europe, Paris, France.
- Utrecht University and National Health Care Institute, Utrecht, the Netherlands.
Zitieren
APA
Costa, E., Girotti, S., Elayan, S., Castellani, C., Cavaller Bellaubi, M., Goettsch, W., Radulović, M., Rocha, J., Russo, P., Simoens, S., & Leopold, C. (2026). Timing and rate of reimbursement for cystic fibrosis modulator therapies in EU countries. Journal of Cystic Fibrosis. https://doi.org/10.1016/j.jcf.2026.07.008
Vancouver
Costa E, Girotti S, Elayan S, Castellani C, Cavaller Bellaubi M, Goettsch W, et al. Timing and rate of reimbursement for cystic fibrosis modulator therapies in EU countries. Journal of Cystic Fibrosis. 2026. doi:10.1016/j.jcf.2026.07.008
BibTeX
@article{Costa2026,
author = {Costa, Enrico and Girotti, Silvia and Elayan, Saif and Castellani, Carlo and Cavaller Bellaubi, Maria and Goettsch, Wim and Radulović, Momir and Rocha, João and Russo, Pierluigi and Simoens, Steven and Leopold, Christine},
title = {Timing and rate of reimbursement for cystic fibrosis modulator therapies in EU countries},
journal = {Journal of Cystic Fibrosis},
year = {2026},
doi = {10.1016/j.jcf.2026.07.008}
}
EUVIMED